The patient presents with Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis (SJS/TEN) overlap syndrome (22% BSA detachment falls in the 10–30% overlap zone), triggered by allopurinol. The pathogenesis involves CD8 cytotoxic T-cell-mediated keratinocyte apoptosis driven by granulysin and FasL, often associated with HLA-B58:01 in allopurinol-exposed patients. According to the Bastuji-Garin SCORTEN criteria and UK BAD 2016 guidelines, the immediate management (option B) mandates: (1) immediate discontinuation of the offending drug (allopurinol) — every day of delay increases mortality; (2) transfer to a burn ICU for specialized care and monitoring; (3) calculation of SCORTEN score within 24 hours and again at 72 hours to stratify mortality risk (7 parameters: age >40, malignancy, HR >120, BSA detached >10%, BUN >28 mg/dL, glucose >252, bicarbonate <20); and (4) aggressive supportive care* including fluid resuscitation at approximately ⅔ of Parkland formula, warm environment, non-adherent dressings, avoidance of debridement of still-adherent skin, early ophthalmology consult, nutritional support, and DVT prophylaxis. This approach directly addresses the life-threatening nature of SJS/TEN overlap and prevents progression to full TEN.
Bastuji-Garin SCORTEN, J Invest Dermatol 2000; UK SJS/TEN Guidelines (BAD) 2016; Wang et al. Etanercept RCT, J Clin Invest 2018
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.